TGEN (TGEN) Stock Price & Analysis
TGEN (TGEN) rose 2.62% to USD 3.13 as of September 8, 2026 at 12:44 UTC, according to Nexqual real-time market data.
TGEN last closed at USD 3.13; the session ranged USD 3.02–3.19 on volume of 157,931 shares. Market capitalization is —, with a 52-week range of USD 1.94–12.07 (ASE). Source: Nexqual, September 8, 2026 at 12:44 UTC.
Key Statistics (as of September 8, 2026 at 12:44 UTC)
| Price | USD 3.13 |
|---|---|
| Change | ▲ 2.62% (up) |
| Previous Close | USD 3.13 |
| Open | USD 3.13 |
| Day Range | USD 3.02 – 3.19 |
| 52-Week Range | USD 1.94 – 12.07 |
| Volume | 157,931 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (TGEN)
Nexqual's technical model rates TGEN "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 12:44 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 42.92 (neutral) |
| vs SMA50 | Below (USD 3.7) |
| MACD | -0.22 (negative) |
From TGEN's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIOM | Biomolecular Life Holdings, Inc. | USD 0.41 | ▼ 14.55% |
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.15 | ▲ 7.14% |
| NGEN | NervGen Pharma Corp. | USD 2.33 | ▲ 0% |
| GNTA | Genenta Science S.p.A. | USD 0.96 | ▼ 1.83% |
| VRA | Vera Bradley, Inc. | USD 3.35 | ▲ 5.35% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:44 UTC. This page is informational and not investment advice.